BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34800721)

  • 1. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.
    Golabi P; Paik JM; Eberly K; de Avila L; Alqahtani SA; Younossi ZM
    Ann Hepatol; 2022; 27(1):100556. PubMed ID: 34800721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.
    Kim D; Adejumo AC; Yoo ER; Iqbal U; Li AA; Pham EA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2019 Oct; 157(4):1055-1066.e11. PubMed ID: 31251928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
    Kim D; Li AA; Gadiparthi C; Khan MA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2018 Oct; 155(4):1154-1163.e3. PubMed ID: 30009816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
    Stepanova M; Rafiq N; Younossi ZM
    Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
    Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
    Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.
    Munteanu M; Pais R; Peta V; Deckmyn O; Moussalli J; Ngo Y; Rudler M; Lebray P; Charlotte F; Thibault V; Lucidarme O; Ngo A; Imbert-Bismut F; Housset C; Thabut D; Ratziu V; Poynard T;
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1117-1127. PubMed ID: 30334263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry).
    Burra P; Senzolo M; Adam R; Delvart V; Karam V; Germani G; Neuberger J; ;
    Am J Transplant; 2010 Jan; 10(1):138-48. PubMed ID: 19951276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past exposure to hepatitis B: a risk factor for increase in mortality?
    Jinjuvadia R; Liangpunsakul S; Antaki F
    J Clin Gastroenterol; 2014 Mar; 48(3):267-71. PubMed ID: 23751854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States.
    Paik JM; Golabi P; Biswas R; Alqahtani S; Venkatesan C; Younossi ZM
    Hepatol Commun; 2020 Jun; 4(6):890-903. PubMed ID: 32490324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiologies of chronic liver diseases in Hong Kong.
    Fung KT; Fung J; Lai CL; Yuen MF
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):659-64. PubMed ID: 17625435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deaths from chronic liver disease and viral hepatitis, Multnomah County, Oregon, 2000.
    Thomas AR; Zaman A; Bell BP
    J Clin Gastroenterol; 2007 Oct; 41(9):859-62. PubMed ID: 17881933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.
    Setiawan VW; Stram DO; Porcel J; Lu SC; Le Marchand L; Noureddin M
    Hepatology; 2016 Dec; 64(6):1969-1977. PubMed ID: 27301913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease.
    Hong YS; Sinn DH; Gwak GY; Cho J; Kang D; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    World J Gastroenterol; 2016 Apr; 22(14):3785-92. PubMed ID: 27076763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
    Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
    Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.